Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 40.49 TWD
Change Today +1.19 / 3.03%
Volume 71.0K
4159 On Other Exchanges
As of 2:49 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

fountain biopharma inc (4159) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/16/14 - 119.87
52 Week Low
04/30/15 - 38.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for FOUNTAIN BIOPHARMA INC (4159)

Related News

No related news articles were found.

fountain biopharma inc (4159) Related Businessweek News

No Related Businessweek News Found

fountain biopharma inc (4159) Details

Fountain Biopharma Inc. develops humanized monoclonal antibodies for the treatment of allergic disorders and cancers. Its products under preclinical stage include FB704A for the treatment of rheumatoid arthritis; FB121 for treating AIDS; and FB811 used for the treatment of non-hodgkin’s lymphoma. The company’s products under Phase I stage comprise FB825 and FB317 for treating allergic asthma. The company was founded in 2010 and is headquartered in Taipei, Taiwan.

Founded in 2010

fountain biopharma inc (4159) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

fountain biopharma inc (4159) Key Developments

Fountain Biopharma Inc., Annual General Meeting, Jun 27, 2014

Fountain Biopharma Inc., Annual General Meeting, Jun 27, 2014.

Fountain Biopharma Inc. Presents at BIO International Convention, Jun-24-2014 04:45 PM

Fountain Biopharma Inc. Presents at BIO International Convention, Jun-24-2014 04:45 PM. Venue: San Diego Convention Center, San Diego, California, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4159:TT 40.49 TWD +1.19

4159 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4159.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4159 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5,694.7x
Price/Book 3.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5,310.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNTAIN BIOPHARMA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at